CellVax

CellVax

Verified
Cellvax | Preclinical CRO | Expertise in Oncology and Osteoarthritis.

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2017201820192020202120222023
Revenues0000000000000000000000000000
% growth20 %(26 %)(83 %)413 %33 %-80 %
EBITDA0000000000000000000000000000
% EBITDA margin39 %38 %(588 %)40 %---
Profit0000000000000000000000000000
% profit margin39 %64 %(451 %)47 %---
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

$0.0

round

€260k

Grant
Total Funding000k

Recent News about CellVax

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.